122 related articles for article (PubMed ID: 36220450)
1. Screening and identification of CNIH4 gene associated with cell proliferation in gastric cancer based on a large-scale CRISPR-Cas9 screening database DepMap.
Zhang H; Lin Y; Zhuang M; Zhu L; Dai Y; Lin M
Gene; 2023 Jan; 850():146961. PubMed ID: 36220450
[TBL] [Abstract][Full Text] [Related]
2. CRISPR-cas9 Screening Identified Lethal Genes Enriched in Cell Cycle Pathway and of Prognosis Significance in Breast Cancer.
Sun X; Wang Z; Chen X; Shen K
Front Cell Dev Biol; 2021; 9():646774. PubMed ID: 33816496
[TBL] [Abstract][Full Text] [Related]
3. Identification of UBE2I as a Novel Biomarker in ccRCC Based on a Large-Scale CRISPR-Cas9 Screening Database and Immunohistochemistry.
Li F; Lai L; You Z; Cheng H; Guo G; Tang C; Xu L; Liu H; Zhong W; Lin Y; Wang Q; Lin Y; Wei Y
Front Mol Biosci; 2022; 9():813428. PubMed ID: 35211510
[No Abstract] [Full Text] [Related]
4. CRISPR-cas9 screening identified lethal genes enriched in Hippo kinase pathway and of predictive significance in primary low-grade glioma.
Mijiti M; Maimaiti A; Chen X; Tuersun M; Dilixiati M; Dilixiati Y; Zhu G; Wu H; Li Y; Turhon M; Abulaiti A; Maimaitiaili N; Yiming N; Kasimu M; Wang Y
Mol Med; 2023 May; 29(1):64. PubMed ID: 37183261
[TBL] [Abstract][Full Text] [Related]
5. Identification of LARS as an essential gene for osteosarcoma proliferation through large-Scale CRISPR-Cas9 screening database and experimental verification.
Chen W; Lin Y; Jiang M; Wang Q; Shu Q
J Transl Med; 2022 Aug; 20(1):355. PubMed ID: 35962451
[TBL] [Abstract][Full Text] [Related]
6. CRISPR-Cas9 Screening of Kaposi's Sarcoma-Associated Herpesvirus-Transformed Cells Identifies XPO1 as a Vulnerable Target of Cancer Cells.
Gruffaz M; Yuan H; Meng W; Liu H; Bae S; Kim JS; Lu C; Huang Y; Gao SJ
mBio; 2019 May; 10(3):. PubMed ID: 31088931
[TBL] [Abstract][Full Text] [Related]
7. Integrated analysis based on vesicle trafficking-related genes identifying CNIH4 as a novel therapeutic target for glioma.
Fang Z; Kong F; Zeng J; Zhang Z; Wang Y; Wang Y; Duan J; Chen L; Wang J; Liu F
Cancer Med; 2023 Jun; 12(11):12943-12959. PubMed ID: 37062068
[TBL] [Abstract][Full Text] [Related]
8. SFPQ promotes the proliferation, migration and invasion of hepatocellular carcinoma cells and is associated with poor prognosis.
Lin Y; Zhong W; Lin Q; Ye Y; Li S; Chen H; Liu H; Xu L; Zhuang W; Chen S; Lin Y; Wang Q
Am J Cancer Res; 2023; 13(6):2269-2284. PubMed ID: 37424798
[TBL] [Abstract][Full Text] [Related]
9. Characteristics and prognostic value of potential dependency genes in clear cell renal cell carcinoma based on a large-scale CRISPR-Cas9 and RNAi screening database DepMap.
Shi B; Ding J; Qi J; Gu Z
Int J Med Sci; 2021; 18(9):2063-2075. PubMed ID: 33850477
[TBL] [Abstract][Full Text] [Related]
10. Novel molecular classification and prognosis of papillary renal cell carcinoma based on a large-scale CRISPR-Cas9 screening and machine learning.
Liu C; Yuan ZY; Zhang XX; Chang JJ; Yang Y; Sun SJ; Du Y; Zhan HQ
Heliyon; 2024 Jan; 10(1):e23184. PubMed ID: 38163209
[TBL] [Abstract][Full Text] [Related]
11. CRISPR-Cas9 screening identified lethal genes enriched in necroptosis pathway and of prognosis significance in osteosarcoma.
Cheng L; Xiong W; Li S; Wang G; Zhou J; Li H
J Gene Med; 2023 Dec; 25(12):e3563. PubMed ID: 37421290
[TBL] [Abstract][Full Text] [Related]
12. Identification of NCAPG as an Essential Gene for Neuroblastoma Employing CRISPR-Cas9 Screening Database and Experimental Verification.
Jia Y; Yang J; Chen Y; Liu Y; Jin Y; Wang C; Gong B; Zhao Q
Int J Mol Sci; 2023 Oct; 24(19):. PubMed ID: 37834394
[TBL] [Abstract][Full Text] [Related]
13. Identifying novel therapeutic targets in gastric cancer using genome-wide CRISPR-Cas9 screening.
Zeng Z; Zhang X; Jiang CQ; Zhang YG; Wu X; Li J; Tang S; Li L; Gu LJ; Xie XY; Jiang YA
Oncogene; 2022 Apr; 41(14):2069-2078. PubMed ID: 35177812
[TBL] [Abstract][Full Text] [Related]
14. Integrated bioinformatics analysis for differentially expressed genes and signaling pathways identification in gastric cancer.
Yang C; Gong A
Int J Med Sci; 2021; 18(3):792-800. PubMed ID: 33437215
[No Abstract] [Full Text] [Related]
15. Evaluation of CRISPR/Cas9 System Effects on Knocking Out NEAT1 Gene in AGS Gastric Cancer Cell Line with Therapeutic Perspective.
Haghighi N; Doosti A; Kiani J
J Gastrointest Cancer; 2022 Sep; 53(3):623-631. PubMed ID: 34357544
[TBL] [Abstract][Full Text] [Related]
16. [Screening of cell cycle-related genes regulated by KIAA0101 in gastric cancer].
Wang Z; Dang C; Yan R; Zhang H; Yuan D; Li K
Nan Fang Yi Ke Da Xue Xue Bao; 2018 Sep; 38(10):1151-1158. PubMed ID: 30377125
[TBL] [Abstract][Full Text] [Related]
17. Identification of putative drugs for gastric adenocarcinoma utilizing differentially expressed genes and connectivity map.
Chen ZX; Zou XP; Yan HQ; Zhang R; Pang JS; Qin XG; He RQ; Ma J; Feng ZB; Chen G; Gan TQ
Mol Med Rep; 2019 Feb; 19(2):1004-1015. PubMed ID: 30569111
[TBL] [Abstract][Full Text] [Related]
18. Genome-wide CRISPR/Cas9 knockout screening uncovers ZNF319 as a novel tumor suppressor critical for breast cancer metastasis.
Wang L; Zhou L; Li M; Zhao J; Liu Y; Chen Y; Qin X; Wang S; Chen H; Piao Y; Xiang R; Li J; Shi Y
Biochem Biophys Res Commun; 2022 Jan; 589():107-115. PubMed ID: 34902746
[TBL] [Abstract][Full Text] [Related]
19. Exome Array Analysis Identifies Variants in SPOCD1 and BTN3A2 That Affect Risk for Gastric Cancer.
Zhu M; Yan C; Ren C; Huang X; Zhu X; Gu H; Wang M; Wang S; Gao Y; Ji Y; Miao X; Yang M; Chen J; Du J; Huang T; Jiang Y; Dai J; Ma H; Zhou J; Wang Z; Hu Z; Ji G; Zhang Z; Shen H; Shi Y; Jin G
Gastroenterology; 2017 Jun; 152(8):2011-2021. PubMed ID: 28246015
[TBL] [Abstract][Full Text] [Related]
20. Identification of the Transcriptional Networks and the Involvement in Angiotensin II-Induced Injury after CRISPR/Cas9-Mediated Knockdown of Cyr61 in HEK293T Cells.
Wang J; Fu D; Senouthai S; Jiang Y; Hu R; You Y
Mediators Inflamm; 2019; 2019():8697257. PubMed ID: 31148949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
